Robert Bayer

1.1k total citations
23 papers, 754 citations indexed

About

Robert Bayer is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Robert Bayer has authored 23 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Robert Bayer's work include Lymphoma Diagnosis and Treatment (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Mesenchymal stem cell research (3 papers). Robert Bayer is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Mesenchymal stem cell research (3 papers). Robert Bayer collaborates with scholars based in United States and Canada. Robert Bayer's co-authors include Patrick J. Stiff, David Peace, Phillip M. Friden, Ronald K. Potkul, Scott D. Putney, Lee Walus, Raymond T. Bartus, Vincent Charles, Jeffrey H. Kordower and Susan G. Fisher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Robert Bayer

23 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Bayer United States	17	262	215	144	131	130	23	754
Sang Ho Kim South Korea	15	235 0.9×	95 0.4×	64 0.4×	199 1.5×	88 0.7×	33	673
Alessandro Pastore Germany	16	182 0.7×	259 1.2×	195 1.4×	384 2.9×	179 1.4×	33	885
Marie‐Pierre Moles France	6	286 1.1×	81 0.4×	255 1.8×	144 1.1×	113 0.9×	13	710
Malwina Suszyńska United States	20	152 0.6×	229 1.1×	59 0.4×	567 4.3×	192 1.5×	42	1.1k
Carrie Fitzpatrick United States	17	330 1.3×	76 0.4×	184 1.3×	465 3.5×	97 0.7×	33	1.3k
Elizabeth M. Jablonski United States	11	206 0.8×	352 1.6×	27 0.2×	505 3.9×	146 1.1×	11	1.1k
Eric Labouyrie France	13	295 1.1×	52 0.2×	340 2.4×	156 1.2×	212 1.6×	33	777
Frédéric Mourcin France	17	315 1.2×	151 0.7×	179 1.2×	298 2.3×	172 1.3×	31	1.2k
Marit E. Hystad Norway	14	134 0.5×	83 0.4×	91 0.6×	328 2.5×	76 0.6×	19	640
Marianne Jacobsen Denmark	13	110 0.4×	63 0.3×	59 0.4×	132 1.0×	45 0.3×	20	599

Countries citing papers authored by Robert Bayer

Since Specialization

Citations

This map shows the geographic impact of Robert Bayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bayer more than expected).

Fields of papers citing papers by Robert Bayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bayer. The network helps show where Robert Bayer may publish in the future.

Co-authorship network of co-authors of Robert Bayer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bayer. A scholar is included among the top collaborators of Robert Bayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bayer. Robert Bayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allen, Pamela B., Xinyan Lu, Qing Chen, et al.. (2022). Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma. Blood Advances. 7(12). 2670–2676. 19 indexed citations

Allen, Pamela B., Hatice Savas, Andrew M. Evens, et al.. (2020). Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma. Blood. 137(10). 1318–1326. 84 indexed citations

Lomelin, Daniel, et al.. (2017). Long-Term Effectiveness of Strattice in the Laparoscopic Closure of Paraesophageal Hernias. Surgical Innovation. 24(3). 259–263. 7 indexed citations

Karmali, Reem, Mohamad Kassar, Parameswaran Venugopal, et al.. (2011). Safety and Efficacy of Combination Therapy with Fludarabine, Mitoxantrone, and Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan and Maintenance Rituximab as Front-Line Therapy for Patients With Follicular or Marginal Zone Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 11(6). 467–474. 17 indexed citations

Karmali, Reem, Mohamad Kassar, Antonio Jiménez, et al.. (2010). Update on a Prospective Study Evaluating the Safety and Efficacy of Combination Therapy with Fludarabine, Mitoxantrone and Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan and Maintenance Rituximab as Front Line Therapy for Patients with Indolent Lymphomas. Blood. 116(21). 3946–3946. 2 indexed citations

Shah, Bhavin C., et al.. (2009). Does type of mesh used have an impact on outcomes in laparoscopic inguinal hernia?. The American Journal of Surgery. 198(6). 759–764. 23 indexed citations

Stiff, Pat, C.F. LeMaistre, Robert Bayer, et al.. (2001). A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation. Bone Marrow Transplantation. 28(3). 295–303. 25 indexed citations

Sosman, Jeffrey A., Patrick J. Stiff, Robert Bayer, et al.. (2001). Pilot Trial of Interleukin-2 With Granulocyte Colony-Stimulating Factor for the Mobilization of Progenitor Cells in Advanced Breast Cancer Patients Undergoing High-Dose Chemotherapy: Expansion of Immune Effectors Within the Stem-Cell Graft and Post–Stem-Cell Infusion. Journal of Clinical Oncology. 19(3). 634–644. 21 indexed citations

Cairncross, Gregory, Lode J. Swinnen, Robert Bayer, et al.. (2000). Myeloablative chemotherapy for recurrent aggressiveoligodendroglioma. Neuro-Oncology. 2(2). 114–119. 27 indexed citations

10.

Stiff, Patrick J., Bohao Chen, Wilbur A. Franklin, et al.. (2000). Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood. 95(6). 2169–2174. 70 indexed citations

11.

Bowman, J. E., Giselle Corbie‐Smith, Peter Lurie, et al.. (1999). Tuskegee as a metaphor [1] (multiple letters). 285(5424). 47–50. 3 indexed citations

12.

Stiff, Patrick J., Robert Bayer, Ronald K. Potkul, et al.. (1997). High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients.. Journal of Clinical Oncology. 15(4). 1309–1317. 90 indexed citations

13.

Moskowitz, Craig H., Patrick J. Stiff, Michael S. Gordon, et al.. (1997). Recombinant Methionyl Human Stem Cell Factor and Filgrastim for Peripheral Blood Progenitor Cell Mobilization and Transplantation in Non-Hodgkin's Lymphoma Patients — Results of a Phase I/II Trial. Blood. 89(9). 3136–3147. 84 indexed citations

14.

Stiff, Patrick J., et al.. (1995). A Phase II Trial of High-Dose Mitoxantrone, Carboplatin, and Cyclophosphamide with Autologous Bone Marrow Rescue for Recurrent Epithelial Ovarian Carcinoma: Analysis of Risk Factors for Clinical Outcome. Gynecologic Oncology. 57(3). 278–285. 26 indexed citations

15.

Sosman, Jeffrey A., Patrick J. Stiff, Robert Bayer, et al.. (1995). A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy.. PubMed. 16(5). 655–61. 4 indexed citations

16.

Stiff, Pat, et al.. (1995). High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial.. PubMed. 1(12). 1495–502. 5 indexed citations

17.

Kordower, Jeffrey H., Vincent Charles, Robert Bayer, et al.. (1994). Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease.. Proceedings of the National Academy of Sciences. 91(19). 9077–9080. 92 indexed citations

18.

Reyes, Cesar V., et al.. (1993). Malignant cystic epithelial‐stromal tumor of the prostate. Diagnostic Cytopathology. 9(3). 314–317. 3 indexed citations

19.

Nand, Sucha, et al.. (1991). Granulocyte‐macrophage colony stimulating factor for the treatment of drug induced agranulocytosis. American Journal of Hematology. 37(4). 267–269. 26 indexed citations

20.

Glenn, E. M., Barbara J. Bowman, Robert Bayer, & Curtis E. Meyer. (1961). HYDROCORTISONE AND SOME OF ITS EFFECTS ON INTERMEDIARY METABOLISM I. IN VIVO STUDIES. Endocrinology. 68(3). 386–410. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact